安邦制药 (874011.OC)

+ 收藏

财务摘要(报告期)(安邦制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
每股指标:
 每股收益 - 基本(元) 0.040.640.510.560.18
 每股收益 - 稀释(元) 0.040.640.510.560.18
 每股收益 - 期末股本摊薄(元) 0.040.630.500.560.18
 每股净资产BPS(元) 3.313.603.483.533.16
 每股经营活动产生的现金流量净额(元) 0.20-0.59-0.671.960.46
 每股营业收入(元) 1.695.373.115.302.24
关键比率:
 净资产收益率 - 摊薄(%) 1.2317.5614.4415.935.63
 净资产收益率 - 加权(%) 1.1418.3913.4017.155.96
 净资产收益率 - 平均(%) 1.1817.8914.4417.315.80
 净资产收益率 - 扣除(%) -1.0115.4413.2114.285.55
 总资产净利率 - 平均(%) 0.8111.639.3911.144.31
 总资产报酬率ROA(%) 0.0412.8810.5911.644.34
 投入资本回报率ROIC(%) 0.1817.0013.8416.595.43
 销售毛利率(%) 35.6240.8345.2241.1937.52
 销售净利率(%) 2.2812.1416.9511.128.37
 资产负债率(%) 22.3424.7327.4941.5926.25
 资产周转率(倍) 0.360.960.551.000.51
 销售商品提供劳务收到的现金/营业收入(%) 107.6790.4069.99136.50120.93
 营业利润同比增长率(%) -94.9017.21200.93117.08-
 营业收入同比增长率(%) -45.792.5840.3327.47-
 利润总额同比增长率(%) -94.5018.01205.92139.03-
 归属母公司股东的净利润同比增长率(%) -91.8914.47187.92131.55-
 扣非后归属母公司股东的净利润同比增长率(%) -107.0711.92167.24105.13-
 总资产同比增长率(%) -10.92-19.4114.6946.36-
 总负债同比增长率(%) -27.62-52.0920.11115.55-
 净资产同比增长率(%) -4.553.8412.3018.95-
利润表摘要:
 营业总收入(元) 102,375,946.21326,005,469.99188,840,081.29317,792,952.09134,571,852.23
 营业总成本(元) 104,877,622.79290,950,892.34158,038,465.51293,435,300.08127,104,565.16
 营业收入(元) 102,375,946.21326,005,469.99188,840,081.29317,792,952.09134,571,852.23
 营业利润(元) 1,881,172.9545,017,821.3336,901,203.2338,407,411.1812,262,494.75
 利润总额(元) 2,033,240.5744,990,077.5236,974,756.5938,125,247.3812,086,498.98
 净利润(元) 2,332,516.3439,564,782.8331,999,801.0335,327,031.2011,260,348.15
 归属母公司股东的净利润(元) 2,469,041.0538,407,887.2230,432,496.4733,551,825.3010,569,897.89
 非经常性损益(元) 4,493,710.384,645,667.961,809,842.553,385,211.05540,611.43
 归属母公司股东的净利润扣除非经常性损益(元) -2,024,669.3333,762,219.2627,831,566.2730,082,726.0510,414,500.00
资产负债表摘要:
 流动资产(元) 196,563,858.31225,776,289.19220,825,169.88286,258,723.42172,183,942.45
 固定资产(元) 51,037,689.7153,038,090.4255,767,197.8158,108,287.0858,110,230.48
 资产总计(元) 271,430,591.32303,554,737.78304,703,639.33376,648,880.98265,671,277.69
 流动负债(元) 56,246,699.2570,312,963.9479,139,040.07150,958,247.4562,525,650.06
 非流动负债(元) 4,387,542.834,744,960.944,632,768.165,699,215.917,220,893.06
 负债合计(元) 60,634,242.0875,057,924.8883,771,808.23156,657,463.3669,746,543.12
 股东权益(元) 210,796,349.24228,496,812.90220,931,831.10219,991,417.62195,924,734.57
 归属母公司股东的权益(元) 201,156,483.19218,720,422.14210,745,031.39210,641,722.47187,659,795.06
 资本公积(元) 75,822,105.7075,822,105.7075,822,105.7066,837,293.2566,837,293.25
 盈余公积(元) 11,764,857.0711,764,857.078,097,356.438,097,356.435,106,470.64
 未分配利润(元) 52,863,520.4270,427,459.3766,119,569.2675,707,072.7955,716,031.17
现金流量表摘要:
 销售商品提供劳务收到的现金(元) 110,231,995.70294,707,078.94132,170,448.36433,774,804.26162,739,385.87
 经营活动产生的现金净流量(元) 12,008,693.43-35,774,456.02-40,396,999.08117,348,293.1827,820,907.82
 购建固定无形长期资产支付的现金(元) 1,117,851.092,847,059.931,005,818.582,914,371.353,033,530.91
 投资支付的现金(元) ---4,400,000.004,400,000.00
 投资活动产生的现金净流量(元) -900,950.09-2,655,324.80-997,492.20-5,097,761.35-5,424,261.26
 吸收投资收到的现金(元) -10,040,812.4510,040,812.45--
 取得借款收到的现金(元) 3,824,400.007,196,700.004,814,000.007,749,000.004,578,000.00
 筹资活动产生的现金净流量(元) -19,228,087.27-32,278,521.46-27,622,156.71-1,391,752.37-458,832.32
 现金及现金等价物净增加(元) -8,120,343.93-70,708,302.28-69,016,647.99110,858,779.4621,937,814.24
 期末现金及现金等价物余额(元) 104,221,683.01112,342,026.94114,033,681.23183,050,329.2294,129,364.00
 折旧与摊销(元) 5,308,399.9911,721,886.445,942,472.019,285,562.964,679,841.39
公告日期 2024-08-292024-04-262023-08-282023-03-242022-12-01
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院